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Effects of Type 1, 2, and 3 Immunity on the Viral
Susceptibility of Human Keratinocytes

Kimberly Leffler1, Brian Ward, PhD1, Lisa Beck, MD FAAAAI1,
Matthew Brewer, PhD1; 1University of Rochester.
RATIONALE: Atopic dermatitis (AD) is a chronic inflammatory skin
condition characterized by increased susceptibility to cutaneous viral
infections. Type 2 (T2) immunity predominates in AD skin lesions, but
expression profiling has demonstrated involvement of Type 1 (T1) and/or
Type 3 (T3) cytokines. We investigated whether these cell-mediated
immune pathways effect cutaneous viral infection.
METHODS: Human differentiating keratinocytes were treated with
cytokine(s) representative of these immune pathways T1 (IFN-g), T2
(IL-4+IL-13), and T3 (IL-17A) at doses 3,12.5,50,200ng/ml for 48 hours.
Keratinocytes were infected with vaccinia virus (50-100pfu/ml) and
infectivity was quantified via plaque assay and viral titering.
Transepithelial electrical resistance (TEER) was measured over 4 days
to assess cytokine (50ng/ml) effects on barrier function.
RESULTS: T1 (50ng/ml) significantly reduced plaque number (P50.04;
n55-7) and reduced virion production by 44-2170 fold compared to media
(n53). T2 treatment increased plaque count 1-222 fold at all doses
(P<0.02; n58) and increased virion production 15-96 fold (n53). T3
treatment did not significantly effect viral assays. T1 (50ng/ml) significantly increased TEER at day 2 post differentiation, but became statistically decreased by day 4. Neither T2 nor T3 significantly changed TEER.
CONCLUSIONS: IL-4+IL-13 increased viral plaque numbers and virion
production, demonstrating that T2 cytokines make keratinocytes more
permissive to viral infection and dissemination. In contrast, IFN-g reduced
viral infectivity and dissemination, possibly by enhancing barrier function
earlier. IL-17A had no statistically significant effect on viral assays or
TEER. The imbalance of T1 and T2 cytokines in skin lesions may be a key
driver of cutaneous viral infections in AD subjects.
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Exploring Dietary Patterns And The Distribution
Of Atopic Dermatitis In A Birth Cohort Of A
Metropolitan Area In Germany

Lennard Merdha1, Lea Schmidt1, Hanna Hufnagel1, Hannah Wecker1,
Linda Tizek1, Maximilian Schielein1, Stefanie Ziehfreund1, Tilo Biedermann1, Alexander Zink1; 1Technical University of Munich.
RATIONALE: Early life exposures likely affect the development of
atopic diseases. Diet has been considered to be a modifiable factor to
intervene preventively. The aim of the study was to identify dietary patterns
based on the use of supplements during pregnancy.
METHODS: This cross-sectional study was derived from the birth cohort
of the Munich Atopy Prediction Study (MAPS). Data was collected using a
study-specific food frequency questionnaire (FFQ) and follow-up questionnaires of MAPS. By submitting the FFQ 168 mother-child pairs were
included. For analysis hierarchical clustering method and simple matching
coefficient were applied.
RESULTS: Four clusters C1 (n543), C2 (n571), C3 (n546), C4 (n58)
were identified, characterized by folate, iron, iodine, calcium, and omega-3
use. In C1, almost every woman used all supplements with lower omega-3
intake (62.8%). In C1–C3, every woman took folate, against none in C4.
All women in C1 and C2 used iodine, whereas none in C3. Fewest
supplements were used in C3 and C4. Altogether, 34 children were
diagnosed with AD (20.2%), while within C3 the lowest proportion
appeared (15.2%). In C1–C3 most children were predisposed. In C1 and
C2, most infants were exclusively breastfed for more than 4 months; those
in C3 were exclusively breastfed for less than 4 months (47.8%).
CONCLUSIONS: According to our findings, in C3, where relatively few
supplements were used and the proportion of infants breastfed exclusively
for less than four months was relatively high, the rate of AD cases was
lowest. Further studies are needed to clarify these results.
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RATIONALE: Recruitment for research studies is a challenging endeavor
that has been further complicated by the COVID-19 pandemic. While
clinical research was temporarily halted due to the pandemic, it was
hypothesized that study and recruitment restructuring would enable brisk
enrollment when research resumed.
METHODS: A new NIH/ECHO-supported multi-center birth cohort,
‘‘Childhood Allergy and the NeOnatal Environment’’ (CANOE) was
launched in January 2019 across four sites to determine how pre-, peri-,
and post-natal factors influence development of recurrent wheezing and
atopic dermatitis. Study recruitment was halted for nine months due to the
COVID-19 pandemic, during which recruitment and study procedures
were redesigned.
RESULTS: Recruitment strategies were modified to limit in-person
contact, shifting toward alternative HIPAA-compliant methods like
clinician referrals, institutional social media, and telemedicine consenting.
Protocol changes included reducing frequency of in-person visits,
leveraging clinical care visits to collect bio-samples, expanded selfcollection of samples at home, and posting study materials online.
Recruitment rates range from 3-12 families per month per site. In-clinic
recruitment with modifications for social distancing has been successful
across all sites. Other successful strategies have included targeted social
media posts, mailed letters, and email. Rates of consent have been similar
across recruitment strategies and the implementation of multiple recruitment strategies has yielded the highest rates of ongoing consent and
enrollment of mother-infant dyads.
CONCLUSIONS: Study procedures that prioritize health and safety
measures such as social distancing, study participant convenience, and
diversification of recruitment strategies enable continued birth cohort
recruitment and data collection while adhering to public health restrictions
during the pandemic.
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